91 – 100 of 192
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
The serotonin system: a potential target for anti-dyskinetic treatments and biomarker discovery.
(
- Contribution to journal › Article
-
Mark
Animal models of l-DOPA-induced dyskinesia: an update on the current options.
(
- Contribution to journal › Article
-
Mark
Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
- 2011
-
Mark
Microvascular plasticity and neurovascular coupling in the pharmacotherapy of Parkinson's disease
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The locus coeruleus Is Directly Implicated in L-DOPA-Induced Dyskinesia in Parkinsonian Rats: An Electrophysiological and Behavioural Study
(
- Contribution to journal › Article
-
Mark
Parkinson disease: Poor results for retinal cell transplants in Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Putaminal Upregulation of FosB/Delta FosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia
(
- Contribution to journal › Article
-
Mark
Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.
(
- Contribution to journal › Article